Charles River Laboratories International, Inc. (CRL): Operating Income
$25.16M
Year ended 2025-12-27
$90.14M
Trailing 12 months to 2026-06-27
-66.2%
3-year compound annual growth
-43.4%
5-year compound annual growth
-19.0%
10-year compound annual growth
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-27 | $25.16M | -88.9% | 2026-02-18, From 2024-12-29 |
| 2024-12-28 | $227.35M | -63.2% | 2026-02-18, From 2023-12-31 |
| 2023-12-30 | $617.26M | -5.2% | 2026-02-18, From 2023-01-01 |
| 2022-12-31 | $650.98M | +10.4% | 2025-02-19, From 2021-12-26 |
| 2021-12-25 | $589.86M | +36.3% | 2024-02-14, From 2020-12-27 |
| 2020-12-26 | $432.73M | +23.2% | 2023-02-22, From 2019-12-29 |
| 2019-12-28 | $351.15M | +6.0% | 2022-02-16, From 2018-12-30 |
| 2018-12-29 | $331.38M | +15.0% | 2021-02-17, From 2017-12-31 |
| 2017-12-30 | $288.28M | +21.4% | 2020-02-11, From 2017-01-01 |
| 2016-12-31 | $237.55M | +15.1% | 2019-02-13, From 2015-12-27 |
| 2015-12-26 | $206.45M | +16.2% | 2018-02-13, From 2014-12-28 |
| 2014-12-27 | $177.67M | +17.4% | 2017-02-14, From 2013-12-29 |
| 2013-12-28 | $151.40M | -8.7% | 2016-02-12, From 2012-12-30 |
| 2012-12-29 | $165.76M | -4.9% | 2015-02-17, From 2012-01-01 |
| 2011-12-31 | $174.31M | n/m | 2014-02-25, From 2010-12-26 |
| 2010-12-25 | -$298.51M | n/m | 2013-02-27, From 2009-12-27 |
| 2009-12-26 | $169.61M | n/m | 2012-02-27, From 2008-12-28 |
| 2008-12-27 | -$451.84M | n/a | 2011-02-23, From 2007-12-30 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $25.16M | -88.9% |
| Incyte Corp (INCY) | 2025-12-31 | $1.51B | n/m |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $534.93M | +19.7% |
| Icon PLC (ICLR) | 2025-12-31 | $442.85M | -57.1% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $2.18B | -0.9% |
| NRC Health (NRC) | 2025-12-31 | $22.59M | -35.8% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$51.90M | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$68.97M | n/m |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | -$10.33M | n/m |
Compare CRL, INCY, MEDP, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗